Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of the COVID-19 pandemic. More than 274 million individuals have suffered from COVID-19 and over five million people have died from this disease so far. Therefore, there is an urgent need for therapeutic drugs. Repu...

Descripción completa

Detalles Bibliográficos
Autores principales: Strobelt, Romano, Adler, Julia, Paran, Nir, Yahalom-Ronen, Yfat, Melamed, Sharon, Politi, Boaz, Shulman, Ziv, Schmiedel, Dominik, Shaul, Yosef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984672/
https://www.ncbi.nlm.nih.gov/pubmed/35388061
http://dx.doi.org/10.1038/s41598-022-09664-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984672/
https://www.ncbi.nlm.nih.gov/pubmed/35388061
http://dx.doi.org/10.1038/s41598-022-09664-1

Ejemplares similares